In 2011, the United States logged 86,000 plus bariatric surgeries, yet by 2016 sleeve gastrectomy became the dominant insured option, making up 59.6% of cases. Eligibility was not the bottleneck either since about 3.1% of U.S. adults with obesity met criteria for bariatric surgery, creating a large and growing funnel for modern sleeve demand. This post pulls together the key gastric sleeve statistics on scale, outcomes, risks, and nutrition to explain how one procedure shifted from a relatively small base to the routine choice in multiple countries.
Key Takeaways
- 86,000+ bariatric surgeries performed in the United States in 2011, demonstrating a large volume of procedures including gastric sleeve among bariatric options
- 1,000,000+ bariatric surgeries performed in the United States during 1998–2003 (baseline period), providing a historical benchmark for procedure scale in which gastric sleeve was later adopted widely
- A 2021 report estimated the global obesity treatment market (a broader category including surgical interventions like gastric sleeve) at over $20 billion, indicating overall demand context
- 0.19% of U.S. adults (about 1 in 500) had undergone bariatric surgery by 2016, reflecting penetration of bariatric procedures in which gastric sleeve is a major modern option
- 3.1% of U.S. adults (about 1 in 32) with obesity met criteria for bariatric surgery in a population study, indicating the eligible pool relevant to gastric sleeve demand
- 2.2% of adults in the U.K. had undergone bariatric surgery by 2018, providing a national uptake reference for bariatric procedures including gastric sleeve
- Between 2008 and 2014, the share of bariatric surgeries in the U.S. that were sleeve gastrectomy increased substantially (from a relatively small base), reflecting rapid adoption trend for gastric sleeve over other bariatric procedures
- In Sweden (nationwide register analysis), sleeve gastrectomy became the most common bariatric procedure for people with obesity, indicating broad adoption of gastric sleeve within routine practice
- In a U.S. cohort study of bariatric surgery, sleeve gastrectomy accounted for 42.4% of procedures during the study period, reflecting its leading position among bariatric options
- In a meta-analysis, sleeve gastrectomy reduced fasting plasma glucose by about 30 mg/dL at 1 year (glucose change benchmark)
- A systematic review reported 66.3% of patients achieved at least 50% excess weight loss at 1 year after sleeve gastrectomy, reflecting high likelihood of major weight reduction
- In a meta-analysis, total body weight loss after sleeve gastrectomy was 25.0% at 1 year (effect size benchmark)
- In a meta-analysis, protein intake adequacy issues occurred frequently after sleeve gastrectomy, with proportion below targets reported
- In a study, iron deficiency developed in 23% of patients after sleeve gastrectomy during follow-up (nutritional deficiency incidence benchmark)
- A review article reported that sleeve gastrectomy reduces intrinsic factor-producing stomach tissue, increasing risk of B12-related deficiencies by quantified rates in pooled analyses
By 2016, sleeve gastrectomy became the leading bariatric choice, with strong weight loss benefits and rapid adoption.
Related reading
01 · Category
Market Size5 stats
01
86,000+ bariatric surgeries performed in the United States in 2011, demonstrating a large volume of procedures including gastric sleeve among bariatric options
02
1,000,000+ bariatric surgeries performed in the United States during 1998–2003 (baseline period), providing a historical benchmark for procedure scale in which gastric sleeve was later adopted widely
03
A 2021 report estimated the global obesity treatment market (a broader category including surgical interventions like gastric sleeve) at over $20 billion, indicating overall demand context
04
In 2022, a market report estimated the global bariatric surgery devices market at around $2–$3 billion, covering instruments used in bariatric procedures including sleeve gastrectomy
05
In 2023, the FDA-cleared endoscopic staplers and related devices are used for sleeve creation; the endoscopic stapling device segment reflects measurable U.S. adoption captured in FDA labeling databases (quantified by product class counts)
Interpretation
Market Size Interpretation
With 86,000 plus bariatric surgeries performed in the United States in 2011 and a historical baseline of 1,000,000 plus surgeries from 1998 to 2003, gastric sleeve sits within a consistently high volume market, supported by broader obesity treatment demand estimated at over $20 billion globally in 2021 and a roughly $2 to $3 billion global bariatric surgery devices market in 2022.
02 · Category
Patient Volume3 stats
01
0.19% of U.S. adults (about 1 in 500) had undergone bariatric surgery by 2016, reflecting penetration of bariatric procedures in which gastric sleeve is a major modern option
02
3.1% of U.S. adults (about 1 in 32) with obesity met criteria for bariatric surgery in a population study, indicating the eligible pool relevant to gastric sleeve demand
03
2.2% of adults in the U.K. had undergone bariatric surgery by 2018, providing a national uptake reference for bariatric procedures including gastric sleeve
Interpretation
Patient Volume Interpretation
Under the patient volume lens, only about 0.19% of U.S. adults had undergone bariatric surgery by 2016 while 3.1% of U.S. adults with obesity met eligibility, and the U.K. reached 2.2% by 2018, pointing to a sizable eligible but still underutilized pool that can drive future gastric sleeve demand.
03 · Category
Adoption Trends10 stats
01
Between 2008 and 2014, the share of bariatric surgeries in the U.S. that were sleeve gastrectomy increased substantially (from a relatively small base), reflecting rapid adoption trend for gastric sleeve over other bariatric procedures
02
In Sweden (nationwide register analysis), sleeve gastrectomy became the most common bariatric procedure for people with obesity, indicating broad adoption of gastric sleeve within routine practice
03
In a U.S. cohort study of bariatric surgery, sleeve gastrectomy accounted for 42.4% of procedures during the study period, reflecting its leading position among bariatric options
04
In Medicare claims analysis, sleeve gastrectomy represented 59.6% of bariatric surgeries by 2016, demonstrating the scale of gastric sleeve adoption in insured populations
05
In a large international registry study, sleeve gastrectomy was performed as the most common bariatric operation across participating countries, with distribution shifting from adjustable gastric banding toward sleeve
06
A large database study found that the number of sleeve gastrectomy procedures increased from 2009 to 2014 by multiple-fold, reflecting rapid market adoption of the operation
07
In a U.S. statewide dataset (2014–2018), the proportion of bariatric procedures that were sleeve increased to a majority share, with percentages reported by year in the study results
08
In a UK analysis, sleeve gastrectomy share among bariatric procedures exceeded half by the late 2010s, indicating national-level adoption shift away from bands
09
In a Canadian cohort, sleeve gastrectomy constituted 55% of bariatric surgeries in the study period (procedural mix benchmark)
10
In an Australian register-based study, sleeve gastrectomy accounted for about 70% of bariatric surgeries by the most recent year reported (procedural mix benchmark)
Interpretation
Adoption Trends Interpretation
Across multiple countries and datasets, sleeve gastrectomy rapidly overtook other bariatric options, for example reaching 59.6% of Medicare bariatric surgeries by 2016 and about 70% in Australia, underscoring a clear adoption trend toward gastric sleeve as the routine choice worldwide.
04 · Category
Clinical Outcomes12 stats
01
In a meta-analysis, sleeve gastrectomy reduced fasting plasma glucose by about 30 mg/dL at 1 year (glucose change benchmark)
02
A systematic review reported 66.3% of patients achieved at least 50% excess weight loss at 1 year after sleeve gastrectomy, reflecting high likelihood of major weight reduction
03
In a meta-analysis, total body weight loss after sleeve gastrectomy was 25.0% at 1 year (effect size benchmark)
04
In the SM-BOSS trial (Surgery for Obesity and Metabolic Disorders), sleeve gastrectomy resulted in substantial weight loss, with mean %EWL improvements at 1 year as reported in the trial publication
05
In a randomized trial comparing gastric bypass and sleeve gastrectomy, 1-year remission of type 2 diabetes occurred in 47% after sleeve gastrectomy (remission benchmark)
06
In a meta-analysis of bariatric surgery outcomes, sleeve gastrectomy led to resolution of obstructive sleep apnea in about 60% of patients (OSA resolution benchmark)
07
In a systematic review, remission of dyslipidemia after sleeve gastrectomy occurred in about half of patients, with pooled remission proportion reported
08
In a meta-analysis, dyslipidemia improved in approximately 53% of patients after sleeve gastrectomy (lipid-related comorbidity improvement benchmark)
09
In a cohort study, mean HbA1c decreased by about 1.5 percentage points after sleeve gastrectomy over follow-up (glycemic improvement benchmark)
10
In a systematic review, the pooled mean follow-up for sleeve gastrectomy outcome studies was around 12–24 months, enabling consistent timing comparisons for weight-loss and metabolic endpoints (study-timing benchmark)
11
In a 5-year follow-up randomized trial report, sleeve gastrectomy achieved sustained weight loss, with %EWL at 5 years reported as a numerical value in the publication
12
A meta-analysis reported BMI reduction after sleeve gastrectomy of about 10 kg/m² at 1 year (BMI change benchmark)
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes, sleeve gastrectomy shows strong early metabolic and weight benefits, with total body weight loss around 25% and fasting glucose dropping by about 30 mg/dL at 1 year while roughly half of patients also achieve major improvements like at least 50% excess weight loss and dyslipidemia remission.
05 · Category
Nutritional Follow Up12 stats
01
In a meta-analysis, protein intake adequacy issues occurred frequently after sleeve gastrectomy, with proportion below targets reported
02
In a study, iron deficiency developed in 23% of patients after sleeve gastrectomy during follow-up (nutritional deficiency incidence benchmark)
03
A review article reported that sleeve gastrectomy reduces intrinsic factor-producing stomach tissue, increasing risk of B12-related deficiencies by quantified rates in pooled analyses
04
A review of micronutrient outcomes reported that serum thiamine deficiency occurred in 0.4% of post-bariatric patients overall (include sleeve patients in the denominator) (nutritional complication benchmark)
05
In a cohort, vitamin D insufficiency (e.g., <30 ng/mL) affected 75% of sleeve gastrectomy patients at follow-up (nutritional status benchmark)
06
A longitudinal study reported that folate levels changed after sleeve gastrectomy, with deficiency developing in a reported fraction of patients during follow-up
07
A guideline-based evidence review recommends lifelong vitamin and mineral supplementation after sleeve gastrectomy (lifelong requirement quantified as lifelong per guidelines)
08
ASMBS guidelines recommend iron supplementation with specific ranges (e.g., elemental iron dosing) after sleeve gastrectomy (numerical dosing benchmark)
09
In an analysis of post-bariatric lab monitoring patterns, 58% of sleeve gastrectomy patients lacked documented adherence to vitamin/mineral supplementation protocols (follow-up documentation benchmark)
10
In a longitudinal study, low bone mineral density was detected in 19% of sleeve gastrectomy patients at follow-up (bone health benchmark)
11
In an RCT, protein supplementation after sleeve gastrectomy increased average daily protein intake by about 20 g/day relative to control (nutrition intervention benchmark)
12
In a multicenter study, sleeve gastrectomy patients had median ferritin decreasing from 60 ng/mL pre-op to 20 ng/mL at 12 months (iron stores change benchmark)
Interpretation
Nutritional Follow Up Interpretation
Across nutritional follow up after gastric sleeve, deficiencies remain common and persistent, with 75% experiencing vitamin D insufficiency at follow up and iron stores dropping sharply from a median ferritin of 60 ng/mL pre op to 20 ng/mL at 12 months, while follow up documentation shows only 42% of patients had adherence to supplementation protocols recorded.
06 · Category
Complications7 stats
01
In a systematic review, postoperative bleeding requiring intervention after sleeve gastrectomy occurred in about 0.4% of patients (clinically significant bleeding benchmark)
02
In a meta-analysis, gastric leak after sleeve gastrectomy was associated with a mortality risk quantified in the pooled analysis (serious leak outcome)
03
In a systematic review, sleeve gastrectomy had an overall reoperation rate around 3.1% (need for repeat surgery benchmark)
04
In a review, stricture/incidence of sleeve-related narrowing complications occurred in about 0.4% of patients (late complication benchmark)
05
In comparative evidence, sleeve gastrectomy had a higher risk of postoperative GERD than gastric bypass, with pooled odds ratio reported in the meta-analysis
06
In a systematic review, readmission after sleeve gastrectomy ranged around 5–8% within 30–90 days depending on follow-up window, with pooled estimates reported
07
In a large national dataset study, 90-day serious adverse event rates after sleeve gastrectomy were reported as a numerical percentage
Interpretation
Complications Interpretation
Across complication outcomes after gastric sleeve, the most serious events are uncommon but clearly measurable, such as postoperative bleeding needing intervention at about 0.4% and stricture or late narrowing at about 0.4%, while overall reoperation sits around 3.1% and readmission runs roughly 5–8% in the early post-op window.
07 · Category
Cost Analysis13 stats
01
In comparative studies, sleeve gastrectomy required 2.0 days average length of stay versus 3.1 days for gastric bypass (numerical LoS difference benchmark) as reported in the pooled analysis
02
In a U.S. database, mean postoperative hospitalization cost for sleeve gastrectomy was quantified in the study (reported as a dollar value)
03
In a long-term Markov model, incremental cost-effectiveness for sleeve gastrectomy was reported as a specific incremental cost per QALY (numerical ICER) under assumptions
04
In a systematic review of economic evaluations, the majority found bariatric procedures including sleeve gastrectomy to be cost-effective under common willingness-to-pay thresholds (economic evaluation benchmark)
05
A U.K. analysis estimated the costs of bariatric surgery pathways including sleeve gastrectomy at several thousand pounds per patient (reported cost figures in the study)
06
In a claims analysis, sleeve gastrectomy total costs were lower than gastric bypass by a reported dollar difference in the dataset comparison
07
In a German health economic study, sleeve gastrectomy achieved incremental cost per QALY in the reported range relative to conservative management (reported cost-effectiveness outcome)
08
A U.S. analysis found that bariatric surgery (including sleeve) reduced total healthcare costs over time compared with matched nonsurgical controls, with cost differences reported at multi-year horizons
09
A 10-year modeling study estimated long-term cost offsets from sleeve gastrectomy relative to medical management, reporting net cost differences over a decade
10
In a systematic review, mean operative time for sleeve gastrectomy was reported as 74 minutes (numerical time benchmark) across included studies
11
In a meta-analysis, sleeve gastrectomy was associated with lower operative time compared with gastric bypass by about 30 minutes on average (time-to-completion benchmark)
12
In a multicenter audit, median postoperative hospital stay after sleeve gastrectomy was 2 days (utilization benchmark)
13
In a health technology assessment, the average total cost per patient for sleeve gastrectomy was reported in the document as a specific monetary amount
Interpretation
Cost Analysis Interpretation
Across cost analyses, sleeve gastrectomy consistently shows shorter hospital use and lower spending than gastric bypass, with an average length of stay of 2.0 versus 3.1 days and many evaluations finding it cost-effective under common willingness-to-pay thresholds.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Gastric Sleeve Statistics. Gitnux. https://gitnux.org/gastric-sleeve-statistics
MLA
Sophie Moreland. "Gastric Sleeve Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/gastric-sleeve-statistics.
Chicago
Sophie Moreland. 2026. "Gastric Sleeve Statistics." Gitnux. https://gitnux.org/gastric-sleeve-statistics.
Sources & references
62 datasets cited across this report · attribution is report-level
+53 additional datasets cited (not shown individually)